p53-dependent inhibition of mammalian cell survival by a genetically selected peptide aptamer that targets the regulatory subunit of protein kinase CK2

Oncogene

Volumn 25, Issue 56, 2006, Pages 7343-7353

  Martel, V ^a   Filhol, O ^a   Colas, P ^b   Cochet, C ^a  

^a CEA GRENOBLE   (France)

^b Aptanomics SA   (France)

Author keywords

Cell apoptosis; CK2 subunit; IE2 protein; p53 activation; Peptidic inhibitors

Indexed keywords

APOPTOSIS INDUCING FACTOR; APTAMER; CASEIN KINASE II; CASEIN KINASE II BETA; CASPASE; CYTOCHROME C; GLUTATHIONE TRANSFERASE P1; GREEN FLUORESCENT PROTEIN; HOLOENZYME; PEPTIDE; PEPTIDE P1; PROTEIN IE2; PROTEIN P21; PROTEIN P53; SERINE; VIRUS PROTEIN;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL DEATH; CELL SURVIVAL; COMBINATORIAL LIBRARY; CONTROLLED STUDY; ENZYME SUBUNIT; HUMAN; HUMAN CELL; MAMMAL CELL; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SEQUENCE HOMOLOGY; TWO HYBRID SYSTEM;

3T3 CELLS; AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; APTAMERS, PEPTIDE; BASE SEQUENCE; CASEIN KINASE II; CELL SURVIVAL; DNA PRIMERS; HELA CELLS; HUMANS; IMMUNOPRECIPITATION; MICE; MOLECULAR SEQUENCE DATA; SURFACE PLASMON RESONANCE; TUMOR SUPPRESSOR PROTEIN P53;

CYTOMEGALOVIRUS; MAMMALIA;

EID: 33845218891     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209722     Document Type: Article

References (60)

1. Abraham MC, Shaham S. (2004). Trends Cell Biol 14: 184-193.
2. Ahmed K, Gerber DA, Cochet C. (2002). Trends Cell Biol 12: 226-230.
3. Andreau K, Castedo M, Perfettini JL, Roumier T, Pichard E, Souquer S et al. (2004). J Biol Chem 279: 55937-55945.
4. Bibby AC, Litchfield DW. (2005). Int J Biol Sci 1: 67-79.
5. Bjorling-Poulsen M, Siehler S, Wiesmuller L, Meek D, Niefind K, Issinger OG. (2005). Oncogene 24: 6194-6200.
6. Blaydes JP, Hupp TR. (1998). Oncogene 17: 1045-1052.
7. Buchou T, Vernet M, Blond O, Jensen HH, Pointu H, Olsen BB et al. (2003). Mol Cell Biol 23: 908-915.
8. Castedo M, Ferri KF, Blanco J, Roumier T, Larochette N, Barretina J et al. (2001). J Exp Med 194: 1097-1110.
9. Chantalat L, Leroy D, Filhol O, Nueda A, Benitez MJ, Chambaz EM et al. (1999). EMBO J 18: 2930-2940.
10. Chiou SH, Liu JH, Hsu WM, Chen SS, Chang SY, Juan LJ et al. (2001). J Immunol 167: 4098-4103.
11. Colas P, Cohen B, Jessen T, Grishina I, McCoy J, Brent R. (1996). Nature 380: 548-550.
12. Colman-Lerner A, Chin TE, Brent R. (2001). Cell 107: 739-750.
13. Dagher MC, Filhol-Cochet O. (1997). Biotechniques 22: 916-918, 920-922.
14. Dobrowolska G, Meggio F, Szczegielniak J, Muszynska G, Pinna LA. (1992). Eur J Biochem 204: 299-303.
15. el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parson R, Trent JM et al. (1993). Cell 75: 817-825.
16. Estojak J, Brent R, Golemis EA. (1995). Mol Cell Biol 15: 5820-5829.
17. Fabbrizio E, Le Cam L, Polanowska J, Kaczorek M, Lamb N, Brent R et al. (1999). Oncogene 18: 4357-4363.
18. Ferri KF, Kroemer G. (2000). Nat Cell Biol 2: E63-E64.
19. Filhol O, Cochet C, Wedegaertner P, Gill GN, Chambaz EM. (1991). Biochemistry 30: 11133-11140.
20. Filhol O, Martiel JL, Cochet C. (2004). EMBO Rep 5: 351-355.
21. Filhol O, Nueda A, Martel V, Gerber-Scokaert D, Benitez MJ, Souchier C et al. (2003). Mol Cell Biol 23: 975-987.
22. Fraser AG, Kamath RS, Zipperlen P, Martinez-Campos M, Sohrmann M, Ahringer J. (2000). Nature 408: 325-330.
23. Geyer CR, Brent R. (2000). Methods Enzymol 328: 171-208.
24. Ghavidel A, Schultz MC. (2001). Cell 106: 575-584.
25. Golemis EA, Brent R. (1992). Mol Cell Biol 12: 3006-3014.
26. Grein S, Raymond K, Cochet C, Pyerin W, Chambaz EM, Filhol O. (1999). Mol Cell Biochem 191: 105-109.
27. Guerra B, Boldyreff B, Sarno S, Cesaro L, Issinger OG, Pinna LA. (1999a). Pharmacol Ther 82: 303-313.
28. Guerra B, Issinger OG. (1999). Electrophoresis 20: 391-408.
29. Guerra B, Issinger OG, Wang JY. (2003). Oncogene 22: 4933-4942.
30. Guerra B, Siemer S, Boldyreff B, Issinger OG. (1999b). FEBS Lett 462: 353-357.
31. Heriche JK, Lebrin F, Rabilloud T, Leroy D, Chambaz EM, Goldberg Y. (1997). Science 276: 952-955.
32. Hopkins AL, Groom CR. (2002). Nat Rev Drug Discov 1: 727-730.
33. Joza N, Susin SA, Daugas E, Stanford WL, Cho SK, Li CY et al. (2001). Nature 410: 549-554.
34. Keller DM, Zeng X, Wang Y, Zhang QH, Kapoor M, Shu H et al. (2001). Mol Cell 7: 283-292.
35. Ladbury JE, Lemmon MA, Zhou M, Green J, Botfield MC, Schlessinger J. (1995). Proc Natl Acad Sci USA 92: 3199-3203.
36. Leroy D, Filhol O, Quintaine N, Sarrouilhe D, Loue-Mackenbach P, Chambaz EM et al. (1999). Mol Cell Biochem 191: 43-50.
37. Litchfield DW. (2003). Biochem J 369: 1-15.
38. Loizou JI, El-Khamisy SF, Zlatanou A, Moore DJ, Chan DW, Qin J et al. (2004). Cell 117: 17-28.
39. Lowe SW, Sherr CJ. (2003). Curr Opin Genet Dev 13: 77-83.
40. Luo H, Chan DW, Yang T, Rodriguez M, Chen BP, Leng M et al. (2004). Mol Cell Biol 19: 8356-8365.
41. Maizel A, Tassetto M, Filhol O, Cochet C, Prochiantz A, Joliot A. (2002). Development 129: 3545-3553.
42. Martel V, Filhol O, Nueda A, Cochet C. (2002). Ann NY Acad Sci 973: 272-277.
43. Messerle M, Keil GM, Koszinowski UH. (1991). J Virol 65: 1638-1643.
44. Niefind K, Guerra B, Ermakowa I, Issinger OG. (2001). EMBO J 20: 5320-5331.
45. Pinna LA. (2002). J Cell Sci 115: 3873-3878.
46. Pinna LA, Meggio F. (1997). Prog Cell Cycle Res 3: 77.s-97.s.
47. Rich T, Allen RL, Wyllie AH. (2000). Nature 407: 777-783.
48. Ruzzene M, Penzo D, Pinna LA. (2002). Biochem J 364: 41-47.
49. Shimada K, Kondo K, Yamanishi K. (2004). Microbiol Immunol 48: 205-210.
50. Stalter G, Siemer S, Becht E, Ziegler M, Remberger K, Issinger OG. (1994). Biochem Biophys Res Commun 202: 141-147.
51. Stigare J, Buddelmeijer N, Pigon A, Egyhazi E. (1993). Mol Cell Biochem 129: 77-85.
52. Susin SA, Lorenzo HK, Zamzami N, Marzo I, Snow BE, Brothers GM et al. (1999). Nature 397: 441-446.
53. Theis-Febvre N, Filhol O, Froment C, Cazales M, Cochet C, Monsarrat B et al. (2003). Oncogene 22: 220-232.
54. Unger GM, Davis AT, Slaton JW, Ahmed K. (2004). Curr Cancer Drug Targets 4: 77-84.
55. Vogelstein B, Lane D, Levine AJ. (2000). Nature 408: 307-310.
56. Wadd S, Bryant H, Filhol O, Scott JE, Hsieh TY, Everett RD et al. (1999). J Biol Chem 274: 28991-28998.
57. Wiebusch L, Hagemeier C. (2001). EMBO J 20: 1086-1098.
58. Wyllie AH. (1980). Nature 284: 555-556.
59. Zamzami N, Susin SA, Marchetti P, Hirsch T, Gomez-Monterrey I, Castedo M et al. (1996). J Exp Med 183: 1533-1544.
60. Zhou MM, Harlan JE, Wade WS, Crosby S, Ravichandran KS, Burakoff SJ et al. (1995). J Biol Chem 270: 31119-31123.